@FiercePharma: Sunshine in Australia? Critics call for disclosure of pharma payments to individual docs. Report | Follow @FiercePharma
> GlaxoSmithKline ($GSK) asked European regulators to approve a new use for its pneumococcal vaccine, Synflorix, to prevent pneumonia in infants and small children. Report
> Australian public health advocates are lobbying for drugmakers to disclose payments to individual doctors, rather than report payment totals as rules now require. Report
> Bayer's supervisory board officially elected former CEO Werner Wenning as chairman, after a shareholder's election in April. Report
> Japan's Mitsui plans to snap up another 25% stake in the pharmaceutical ingredient maker Arch Pharmalabs, increasing its overall position in the Indian company to 30%. Report
> Reckitt Benckiser tapped Smith & Nephew's Adrian Hennah as its new chief financial officer, counting on Hennah's healthcare experience to help it expand its health brands. Report
> UCB inaugurated its new 65 million euro biotech plant in Belgium, where it plans to turn out antibody-based therapies for clinical studies and develop full-scale manufacturing processes. Report
@FierceMedDev: Life Technologies and Bristol-Myers Squibb are partnering to develop companion Dx. Who's next? Release | Follow @FierceMedDev
@MarkHFierce: With all the problems metal hip implants are causing, some good news: at least they don't appear to trigger cancer. Report | Follow @MarkHFierce
@DamianFierce: Danaher Corp. is spending $338M to pick up Dx company Iris International. News | Follow @DamianFierce
> Life Technologies reels in Bristol-Myers Squibb as companion Dx partner. Article
> Trouble thinking? There may be a brain implant for that. Item
Biotech News
@FierceBiotech: Little NovaDigm races Pfizer, Glaxo in race to develop MRSA vaccines. Item | Follow @FierceBiotech
@JohnCFierce: Targacept sharpens well-used budget ax after another drug flames out. More | Follow @JohnCFierce
@RyanMFierce: Wow. China's BGI buying rival DNA sequencing outfit Complete Genomics for $3.15 per share (value $117.6M). Release | Follow @RyanMFierce
> Sanofi workers plan protests as execs prep for big job cuts next week. Article
> Casualties of an R&D war? Hep C trial patients accuse Bristol-Myers of recklessness. Story
> Threshold shares slammed after lead cancer drug trips on survival goal. News
CRO News
> Pfizer launches joint venture with Chinese API maker. Story
> Patheon lifts profit outlook after strong quarter. News
> INC expands clinical ops in South Korea. Article
> Quintiles signs on to sell Sinclair IS drugs in Mexico. More
Biotech IT News
> Boehringer Ingelheim debuts pharma game 'Syrum' on Facebook. Article
> Pfizer taps cloud computing to gain control of supply chain. Story
> Illumina partners with Partners HealthCare to combine sequencing and software. Report
And Finally ... Cost-cutting in China is spawning violent attacks against hospital doctors and other healthcare workers. Report